Emergent BioSolutions Reports Financial Results For Second Quarter 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.53 +0.19 (3.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.34 | 52 Week High | $44.38 | |||
| Open | $6.37 | 52 Week Low | $24.47 | |||
| Day High | $6.61 | P/E | 326.50 | |||
| Day Low | $6.37 | EPS | $0.02 | |||
| Volume | 189,391 | |||||
